An international team of researchers have introduced a groundbreaking drug, known as the covalent kinase inhibitor, which shows promise in combating treatment-resistant malaria.Developed by chemists ...

The journey to eliminate malaria is complex, hindered by the parasite's adaptability and challenges in vaccine development.

Scientists at Sanaria and Seattle Children's Research Institute's Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria® PfSPZ-LARC2 Vaccine, ...

A new retrospective, laboratory-based observational study provides detailed insights into the causes of fevers of unknown origin in sub-Saharan Africa. Scientists examined 550 patients from Guinea who ...

A new retrospective, laboratory-based observational study provides detailed insights into the causes of fevers of unknown origin in sub-Saharan ...

Scientists at Sanaria and Seattle Children’s Research Institute’s Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria® PfSPZ-LARC2 Vaccine, ...

A new retrospective, laboratory-based observational study provides detailed insights into the causes of fevers of unknown ...

The Health, Development and Anti-Malaria Association (HDAMA) announced that it provided various life-saving medicines, medical equipment,and other health servicessupport to more than 600 health ...